Puqi Pharma Files Second Listing Application with Hong Kong Exchanges on July 24

HKEX-1.77%
According to Hong Kong Exchanges and Clearing, Puqi Pharma, a Beijing-based biotech company focused on treating chronic inflammatory diseases, filed its listing application with the Main Board on July 24. CITIC Securities and Minyin Capital are acting as joint sponsors. The filing marks the company's second attempt to list on HKEX, following an initial application submitted on January 21.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments